Efficacy of trastuzumab for HER-2 positive breast cancer in a real-life setting: A decade of experience under national treatment coverage regulations

Authors :: Fiamma Dellacasa
Luciana Silveira
Lucía Delgado
Agustin Rosich
Rafael Alonso
Jonathan Nuñez
Emiliano Rivero
Camila Mezquita
Natalia Camejo
Cecilia Castillo
Source :: Journal of Clinical Oncology. 36:e18789-e18789
Publication Year :: 2018
Publisher :: American Society of Clinical Oncology (ASCO), 2018.
Abstract: e18789Background: In clinical trials, trastuzumab (TTZ) has shown an overall survival benefit (OS) in patients with HER-2 positive breast cancer (BC), both in the adjuvant and in the metastatic set...

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
business.industry
medicine.medical_treatment
Real life setting
medicine.disease
Clinical trial
Breast cancer
Trastuzumab
Internal medicine
medicine
Overall survival
In patient
skin and connective tissue diseases
business
Adjuvant
medicine.drug

Full Text Access

Tools